Reading view
Interpretable Question Answering with Knowledge Graphs
Insights into the Unknown: Federated Data Diversity Analysis on Molecular Data
Integrating Transparent Models, LLMs, and Practitioner-in-the-Loop: A Case of Nonprofit Program Evaluation
The Right to Be Remembered: Preserving Maximally Truthful Digital Memory in the Age of AI
TinySQL: A Progressive Text-to-SQL Dataset for Mechanistic Interpretability Research
Quantum Natural Language Processing: A Comprehensive Review of Models, Methods, and Applications
LongCodeBench: Evaluating Coding LLMs at 1M Context Windows
With Limited Data for Multimodal Alignment, Let the STRUCTURE Guide You
ACT: Agentic Classification Tree
STAT+: Moderna says key study of its CMV vaccine, expected to be its next big win, failed
Moderna said Wednesday afternoon that its experimental vaccine for cytomegalovirus, a cause of disability in newborns, failed in a Phase 3 trial, a significant setback for a company already facing pressure from Wall Street and the federal government.
The CMV vaccine had been the companyβs lead program prior to the Covid-19 pandemic. Leadership had repeatedly said it could bring in between $2 billion and $5 billion in peak annual sales. Analysts polled by Visible Alpha forecast peak sales of $1.6 billion for the product.
βItβs obviously disappointing,β said Stephen Hoge, Modernaβs president, in an interview.
Continue to STAT+ to read the full storyβ¦


Β© Ruby Wallau for STAT
STAT+: European oncology experts roll out guidance for use of large language models in clinical careΒ
BERLIN β The leading professional organization for European oncologists has rolled out its first set of guidance on how its members should use large language models, a type of artificial intelligence, in cancer medicine.Β
βThe oncology community cannot ignore the potential benefits which AI technology can provide to cancer patients,β the authors of the guidance wrote, while simultaneously acknowledging that there arenβt enough evaluations of the chatbots available to patients or tools available to doctors to address the risks associated with generative AI in medicine.
The guidanceβs release βΒ it was published last Saturday in the Annals of Oncology β coincided with the annual meeting for the European Society for Clinical Oncology in Berlin. The American Society of Clinical Oncology has issued its own set of principles for the responsible use of AI in cancer medicine, but has not released recommendations specific to large language models (LLMs).
Continue to STAT+ to read the full storyβ¦


Β© Adobe
Discovering state-of-the-art reinforcement learning algorithms
Nature, Published online: 22 October 2025; doi:10.1038/s41586-025-09761-x
Discovering state-of-the-art reinforcement learning algorithmsPancreatic cancer relies on opposing signalling pathways to drive its cellular diversity
Nature, Published online: 22 October 2025; doi:10.1038/d41586-025-03133-1
Communication between epithelial and mesenchymal cells in pancreatic cancer leads to a poor prognosis. The molecular basis for this signalling has now been revealed.